Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Koselugo
AstraZeneca / Alexion
Koselugo
(selumetinib)Orphan drugAstraZeneca / Alexion
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Selumetinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2). MEK1/2 proteins are upstream regula...